ADVERSE DRUG REACTION PATTERN OF ANTI-ASTHMATIC DRUGS PRESCRIBED IN ASTHMA OUT-PATIENT DEPARTMENT IN A TERTIARY CARE HOSPITAL
Abstract
PATTERN AND SEVERITY OF ADVERSE
DRUG REACTION OF ANTI-ASTHMATIC
DRUGS PRESCRIBED IN MEDICINE
OUTPATIENT DEPARTMENT IN A TERTIARY
CARE HOSPITAL OBJECTIVE To
study the pattern and severity of adverse
drug reactions of anti-asthmatic drugs in
patients attending Medicine out- patient
department in a tertiary care hospital.
METHODOLOGY The study was conducted
in adult patients with Bronchial
Asthma attending Asthma outpatient of a
tertiary care hospital between August 2013
to October 2013. Study period was 3
months. Sample size was 500. After getting
approval from the Institutional Human
ethics committee, 794 prescriptions were
screened, 500 prescriptions that met the
inclusion criteria were chosen for analysis.
Adverse Drug Reactions (ADR) were
documented in WHO ADR reporting form.
Causality assessment of the ADR was
done by WHO causality assessment scale.
Severity was assessed using
Modified Hartwig Siegel severity assessment
scale.RESULTS Most of the patients
were in the age group of 61-70 years.
Males constituted 34 percentage and females
66 percentage. Beta 2 agonists
were the most commonly prescribed antiasthmatic
drug group. Adverse Drug Reactions
were more common in elderly females.
Tremor was the most common Adverse
Drug Reaction encountered. Most
of the ADR comes under possible category
of WHO causality assessment scale
and were mild.CONCLUSION Beta 2 agonists
were the most commonly prescribed
anti asthmatic drug group. 34 percentage
of patients encountered Adverse Drug Reactions.
Adverse Drug Reactions were
more common in elderly females. Tremor
was the most common Adverse Drug Reaction
encountered. Most of ADRs were
mild and comes under possible category
of WHO causality assessment scale.
Full Text:
PDFReferences
Harrison EB, Stephen HL, Dan FL,
Dennis KL, Larry JJ. Harrison’s principle
of internal medicine. 2001;2:1456–505.
Masoli M, Fabian D, Holt S, Beasley
R. Global burden of asthma. Developed
for the Global initiative for asthma. 2004;
-3.
World health reports 2001. Fifty facts
from the world health report 1998:
Global Health Situation and Trends
-2025. WHO. 2001
Murray CJ, Lopez AD. Global mortality,
disability and the contribution of
risk factors: Global burden of disease
study. Lancet. 1997; 349:1436–42.
National commission on Macroeconomics
and health- Burden of disease
in India. 2005;251:63.
Stock S, Redaelli M, Luengen M,
Wendland G, Civello D, Lauterbach
KW: Asthma: prevalence and cost of
illness. European Respiratory Journal.
; 25: 247-53.
Geneva: World Health organization.
WHO. Requirements for adverse drug
reaction reporting. 1975; 1039–109.
Gross F. Drug utilization therapy
and practice. The present situation in
the Federal Republic of Germany.
European Journal Clinical Pharmacology
;19:387-94.
Stolley PD, Lasagna L. Prescribing
patterns of physicians. Journal of
chronic diseases 1969; 22:395-405.
JAMA 1998; 279: 1200-1205
Udomratn P, Lin KM, Singh BS,
Chui E, editors. Outpatient prescribing
practices in Asian Countries.
Ethno-psychopharmacology: Advances
in current practice. Cambridge:
Cambridge University Press,
: 135-143.
Uppsala Monitoring Centre (2006),
the use of the World Health Organization-
Uppsala Monitoring Centre
(WHO-UMC) system for standardised
case causality assessment. Accessed
f r o m : h t t p : / / w h o - u m c . o r g /
graphics/4409.pdf. 2012
Hartwig SC, Siegel J, Schneider PJ.
Preventability and severity assessment
in reporting adverse drug reactions. Am
J Hosp Pharm. 1992;49:2229–32.
Kallergis EM, Manios EG, Kanoupakis
EM, Schiza SE, Mavrakis HE,
Klapsinos NK, et al. Acute electrophysiologic
effects of inhaled salbutamol in
humans. Chest. 2005;127: 2057–63.
Bajaj A, Balakrishna S, Sawarkar S.
Assessment of therapeutic performances
of inhalation aerosols and clinical
pharmacist’s services in PFT lab. Indian
J Hosp Pham. 1999; 36:138–42.
Carter WJ et al, Selective beta2 agonists
– side effects". British National Formulary
th edition. London: BMJ Publishing
Group Ltd and Royal Pharmaceutical
Society publishing, 2008.
Kaminstein, David. "Steroid withdrawal".
Medicinenet. 23 December
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University